ROLE OF HEPARIN IN THE ACTIVATION AND MIGRATION OF PRIMARY HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS (HUVECS) FOLLOWING SIGNAL TRANSDUCTION BY CD44 AND ITS LIGAND HYALURONIC ACID
暂无分享,去创建一个
[1] V. Lokeshwar. Clinical and biologic relevance of hyaluronic acid and its fragments , 2004 .
[2] I. Fidler,et al. Regulation of neoplastic angiogenesis. , 2000, Journal of the National Cancer Institute. Monographs.
[3] V. Lokeshwar,et al. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. , 2000, The Journal of biological chemistry.
[4] I. Fidler. Angiogenesis and cancer metastasis. , 2000, Cancer journal.
[5] D. Mangham,et al. The normal structure and function of CD44 and its role in neoplasia. , 1998, Molecular pathology : MP.
[6] R. Klemke,et al. Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis , 1998, The Journal of cell biology.
[7] Ronit Vogt Sionov,et al. CD44: structure, function, and association with the malignant process. , 1997, Advances in cancer research.
[8] N Iida,et al. The Cell Adhesion Molecule, GP116, Is a New CD44 Variant (ex14/v10) Involved in Hyaluronic Acid Binding and Endothelial Cell Proliferation* , 1996, The Journal of Biological Chemistry.
[9] E. Turley,et al. HA receptors: Regulators of signalling to the cytoskeleton , 1996, Journal of cellular biochemistry.
[10] W. Stetler-Stevenson,et al. Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.
[11] C. Soria,et al. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro , 1996, International journal of cancer.
[12] W. Stetler-Stevenson,et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. , 1996, Cell.
[13] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[14] K. Oritani,et al. Glycosylation of CD44 negatively regulates its recognition of hyaluronan , 1995, The Journal of experimental medicine.
[15] D. Cheresh,et al. Definition of two angiogenic pathways by distinct alpha v integrins. , 1995, Science.
[16] R. Savani,et al. Identification of a novel heparin binding domain in RHAMM and evidence that it modifies HA mediated locomotion of ras‐transformed cells , 1994, Journal of cellular biochemistry.
[17] L. Ellis,et al. The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.
[18] J. Sleeman,et al. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. , 1994, Current opinion in cell biology.
[19] R. Auerbach,et al. Angiogenesis inhibition: a review. , 1994, Pharmacology & therapeutics.
[20] C. Underhill,et al. CD44: the hyaluronan receptor. , 1992, Journal of cell science.
[21] R. Hyman,et al. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells , 1992, European journal of immunology.
[22] K. Miyake,et al. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long- term bone marrow cultures , 1990, The Journal of experimental medicine.
[23] W. Carter,et al. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits , 1987, The Journal of cell biology.
[24] J. Folkman,et al. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.
[25] V. Terranova,et al. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin , 1985, The Journal of cell biology.
[26] E. Turley. Purification of a hyaluronate-binding protein fraction that modifies cell social behavior. , 1982, Biochemical and biophysical research communications.